Shareholder Letter from CEO July 2023
July 31, 2023
Dear Imagion Biosystems Shareholders, It has been an incredible first month ramping up as Chief Executive Officer with Team Imagion Biosystems. With this quarter’s 4C
Category: Company Update
Imagion expands collaboration with Siemens Healthineers to United States
June 28, 2023
MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to announce it has
Imagion set to complete the MagSense® HER2 Phase 1 Study
June 21, 2023
Highlights Study achieves enrolment target Study to formally close to new enrolments on 31 July Study results support further clinical development as MRI imaging agent
Imagion Announces New CEO
June 19, 2023
MELBOURNE – Imagion Biosystems (ASX:IBX), a company dedicated to improving healthcare through the early detection of cancer, is pleased to announce it has appointed Isaac
[White Paper] Molecular Imaging: Changing the Way We Look at Cancer
June 1, 2023
Australasian Biotechnology | Vol 33 Number 1 Imagion authored a white paper, published in the April issue of Australasian Biotechnology, discussing current medical imaging technologies,
Employee Spotlight: Dan Inglese, Research Associate
April 12, 2022
Highlighting our dedicated employees who bring both their experience and passions to Imagion Biosystems: What experience do you bring prior to joining IB? I
Employee Spotlight: Carmen Soikowski, Director of Operations
December 13, 2021
Highlighting our dedicated employees who bring both their experience and passions to Imagion Biosystems: We sat down with Carmen Soikowski, who joined us as our